Table 4.
Baseline Serum Lipids, in Tertiles, Predicting Impairment on TMT-Aa
| Lipids in Tertiles
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Total N
|
Categorical
|
2 vs. 1
|
3 vs. 1
|
|||||
| Lipid | Events | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Total SM | 24 | 87 | 1.32 (0.79-2.20) | 0.295 | 0.71 (0.22-2.28) | 0.566 | 1.57 (0.59-4.14) | 0.362 |
| Ceramides | ||||||||
| C16:0 | 23 | 79 | 1.19 (0.73-1.92) | 0.489 | 3.80 (1.23-11.75) | 0.021 | 1.64 (0.52-5.10) | 0.396 |
| C18:0 | 19 | 66 | 0.93 (0.50-1.74) | 0.821 | 1.26 (0.36-4.44) | 0.720 | 0.86 (0.23-3.16) | 0.821 |
| C20:0 | 19 | 66 | 1.22 (0.71-2.11) | 0.473 | 3.63 (1.01-13.02) | 0.048 | 1.63 (0.45-5.86) | 0.456 |
| C22:0 | 23 | 82 | 1.16 (0.68-1.96) | 0.593 | 2.00 (0.64-6.24) | 0.232 | 1.46 (0.46-4.68) | 0.521 |
| C24:1 | 24 | 86 | 1.17 (0.72-1.89) | 0.524 | 2.32 (0.79-6.85) | 0.127 | 1.51 (0.52-4.36) | 0.445 |
| C24:0 | 24 | 88 | 1.40 (0.86-2.28) | 0.174 | 1.60 (0.48-5.38) | 0.447 | 2.02 (0.73-5.54) | 0.174 |
| Galactosyl C12:0 | 20 | 70 | 0.92 (0.53-1.59) | 0.756 | 0.73 (0.22-2.46) | 0.609 | 0.83 (0.28-2.44) | 0.736 |
| Lactosyl C12:0 | 20 | 65 | 1.60 (0.87-2.93) | 0.132 | 2.37 (0.69-8.13) | 0.171 | 2.66 (0.72-9.77) | 0.142 |
| Stearoyl | 24 | 84 | 1.31 (0.81-2.11) | 0.279 | 3.09 (1.02-9.41) | 0.047 | 1.90 (0.63-5.74) | 0.253 |
| Sulfatide | 20 | 73 | 1.28 (0.70-2.35) | 0.428 | 1.21 (0.38-3.88) | 0.745 | 1.63 (0.49-5.47) | 0.425 |
| SM/Cholesterol ratio | 24 | 86 | 1.36 (0.81-2.28) | 0.249 | 1.40 (0.46-4.21) | 0.552 | 1.85 (0.65-5.28) | 0.251 |
| Total cholesterol | 24 | 87 | 0.82 (0.48-1.39) | 0.460 | 0.98 (0.36-2.67) | 0.967 | 0.66 (0.22-1.97) | 0.461 |
HR = Hazard Ratio; CI = Confidence Interval
a
Models control for baseline age, blood glucose level, and BMI